Prostate Cancer - Results from #27360

Prostate specific antigen velocity per prostate volume: A novel tool for prostate biopsy prediction - Abstract August 17, 2011

Calypso Medical sponsors the great prostate cancer challenge race series in five cities August 17, 2011

Changes in prostate specific antigen in hypogonadal men after 12 months of testosterone replacement therapy: Support for the prostate saturation theory - Abstract August 16, 2011

High-intensity focused ultrasound (HIFU): Our experience in the treatment of prostate cancer relapsing after radiotherapy - Abstract August 16, 2011

Coronary artery revascularization and the risk of death in men with prostate cancer - Abstract August 16, 2011

SEER coding standards result in underestimation of positive surgical margin incidence at radical prostatectomy: Results of a systematic audit - Abstract August 16, 2011

Office based transrectal saturation biopsy improves prostate cancer detection compared to extended biopsy in the repeat biopsy population - Abstract August 16, 2011

Integrated safety data from 4 randomized, double-blind, controlled trials of autologous cellular immunotherapy with sipuleucel-T in patients with prostate cancer - Abstract August 16, 2011

Quadriplex model enhances urine-based detection of prostate cancer - Abstract August 16, 2011

Sipuleucel-T in patients with metastatic castration-resistant prostate cancer: An insight for oncologists - Abstract August 16, 2011

Combination of dose escalation with technological advances (intensity-modulated and image-guided radiotherapy) is not associated with increased morbidity for patients with prostate cancer - Abstract August 16, 2011

Editor's Commentary - Circulating estradiol, but not testosterone, is a significant predictor of high-grade prostate cancer in patients undergoing radical prostatectomy August 16, 2011

Androgen deprivation therapy through bilateral orchiectomy: Increased metabolic risks - Abstract August 15, 2011

Dose escalation for patients with decreasing PSA during radiotherapy for elevated PSA after radical prostatectomy improves biochemical progression-free survival : Results of a retrospective study - Abstract August 15, 2011

Insignificant prostate cancer: Charateristics and predictive factors - Abstract August 15, 2011

A phase III extension trial with a 1-Arm crossover from leuprolide to degarelix: Comparison of gonadotropin-releasing hormone agonist and antagonist effect on prostate cancer - Abstract August 15, 2011

Expanded Prostate Cancer Index Composite for Clinical Practice: Development and validation of a practical health related quality of life instrument for use in the routine clinical care of patients with prostate cancer - Abstract August 15, 2011

Regional collaboration to improve radiographic staging practices among men with early stage prostate cancer - Abstract August 15, 2011

B7-H3 over expression in prostate cancer promotes tumor cell progression - Abstract August 12, 2011

Single-fraction high dose rate brachytherapy and hypofractionated external beam radiation therapy in the treatment of intermediate-risk prostate cancer - Long term results - Abstract August 12, 2011

Page 1369 of 1438